Fresenius Medical Care AG
FMCQF
$49.21
$4.219.35%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.88% | 9.13% | 6.00% | 0.16% | 0.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.88% | 9.13% | 6.00% | 0.16% | 0.94% |
| Cost of Revenue | 5.39% | 7.18% | 4.78% | 0.94% | 3.81% |
| Gross Profit | 19.34% | 15.26% | 9.77% | -2.21% | -6.80% |
| SG&A Expenses | 2.06% | -0.79% | 8.25% | -6.18% | -1.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -5.87% | 93.78% | 55.50% | 169.49% | 51.63% |
| Total Operating Expenses | 4.57% | 6.80% | 5.55% | -0.02% | 3.06% |
| Operating Income | 58.25% | 34.77% | 11.36% | 2.37% | -18.33% |
| Income Before Tax | 210.01% | 12.50% | 8.89% | 53.95% | -48.30% |
| Income Tax Expenses | 90.57% | -31.35% | -16.66% | 49.77% | -30.14% |
| Earnings from Continuing Operations | 271.69% | 31.86% | 19.41% | 55.35% | -54.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -59.79% | -9.64% | 7.17% | 21.42% | 26.15% |
| Net Income | 433.92% | 37.18% | 27.00% | 106.59% | -64.75% |
| EBIT | 58.25% | 34.77% | 11.36% | 2.37% | -18.33% |
| EBITDA | 39.58% | 19.16% | 5.30% | -1.11% | -14.78% |
| EPS Basic | 448.02% | 37.80% | 26.99% | 106.63% | -64.76% |
| Normalized Basic EPS | 66.24% | 55.29% | 25.21% | 24.80% | -10.34% |
| EPS Diluted | 467.89% | 37.68% | 26.99% | 108.21% | -65.97% |
| Normalized Diluted EPS | 66.24% | 55.29% | 25.21% | 24.80% | -10.34% |
| Average Basic Shares Outstanding | -2.56% | -0.45% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | -2.56% | -0.45% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | 13.00% | -- | -- | -- | 19.82% |
| Payout Ratio | -- | -- | 0.00% | -- | -- |